Why Veru Stock Is Crashing Today?

The FDA declined to grant Veru Inc’s (NASDAQ: VERU) request for Emergency Use Authorization (EUA) for sabizabulin to treat hospitalized adult patients with moderate to severe COVID-19 who are at high risk for Acute Respiratory Distress Syndrome (ARDS). Separately, the FDA also commented on the company’s proposed confirmatory Phase 3 study protocol for […]

  • The FDA declined to grant Veru Inc’s (NASDAQ: VERU) request for Emergency Use Authorization (EUA) for sabizabulin to treat hospitalized adult patients with moderate to severe COVID-19 who are at high risk for Acute Respiratory Distress Syndrome (ARDS).

  • Separately, the FDA also commented on the company’s proposed confirmatory Phase 3 study protocol for hospitalized moderate to severe COVID-19 patients at risk for ARDS and death that could support a new EUA authorization and/or NDA approval.

  • Also See: Biden Administration Plans To End COVID-19 Public Health Emergency In May.

  • FDA stated that in the potential confirmatory Phase 3 study design: “strong consideration should be given to appropriate time frames for interim analyses so that – should a strong efficacy signal again be observed – the trial could be stopped in an efficient time frame.”

  • Veru expects to communicate the details of the design and timing of this potential Phase 3 confirmatory study soon.

  • In May 2022, pre-EUA meeting with the FDA, the agency indicated that our clinical data package was sufficient to support a EUA submission.

  • In November, as per the briefing documents, the FDA had spelled out its concerns with the pivotal data that Veru submitted.

  • It acknowledged that sabizabulin hit the mark on mortality in the small trial but noted uncertainties or imbalances that, while not problematic individually, “raise questions about the results.”

  • Price Action: VERU shares are down 36.7% at $2.39 during the premarket session on the last check Friday.

Don’t miss real-time alerts on your stocks – join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

This article Why Veru Stock Is Crashing Today? originally appeared on Benzinga.com

.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Next Post

Tucker Carlson 'passionately' hates Trump, and eight more key revelations about Fox News from new Dominion filings

Thu Mar 9 , 2023
New York CNN  —  Fox News continues to be exposed like never before. In legal filings made public Tuesday as part of Dominion Voting Systems’ $1.6 billion defamation lawsuit against the right-wing channel, a trove of private text messages, emails, and deposition transcripts offered a new look at how the […]
Tucker Carlson ‘passionately’ hates Trump, and eight more key revelations about Fox News from new Dominion filings

You May Like